Aminosyn II 3.5
"Jan. 30, 2013 -- PepsiCo recently announced it would remove brominated vegetable oil (BVO) from its Gatorade drinks in response to customer concerns.
Just what is BVO? And what is it doing in your sports drink?
To learn more, we "...
Aminosyn II 3.5% in 5% Dextrose
Aminosyn II 3.5 Side Effects Center
Medical Editor: John P. Cunha, DO, FACOEP
Aminosyn II 3.5% in 5% Dextrose Injection (amino acids) is a combination of amino acids used as a source of nitrogen in the nutritional support of patients in whom for short periods of time oral nutrition cannot be tolerated, is undesirable or inadequate. Common side effects include skin redness, inflammation, and swelling, warm sensation, or infection at the injection site. Flushing, fever, and nausea may also occur.
The total daily dose of Aminosyn II 3.5% in 5% Dextrose Injection to be infused depends on daily protein and caloric requirements and on the patient's metabolic and clinical response. Aminosyn II 3.5% in 5% Dextrose Injection may interact with other drugs. Tell your doctor all medications and supplements you use. During pregnancy, Aminosyn II 3.5% in 5% Dextrose Injection should be used only if prescribed. Consult your doctor before breastfeeding.
Our Aminosyn II 3.5% in 5% Dextrose Injection (amino acids) Side Effects Drug Center provides a comprehensive view of available drug information on the potential side effects when taking this medication.
This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.
What is Prescribing information?
The FDA package insert formatted in easy-to-find categories for health professionals and clinicians.
Aminosyn II 3.5 FDA Prescribing Information: Side Effects
Aminosyn II 3.5% in 5% Dextrose Injection (without electrolyte additives) is hypertonic; it can be infused through a peripheral vein paying great care to the possible occurrence of local reactions. Local reactions consisting of a warm sensation, erythema, phlebitis and thrombosis at the infusion site have occurred with peripheral intravenous infusion of amino acids; in such cases the infusion site should be changed promptly to another vein. Use of large peripheral veins, inline filters, and slower rates of infusion may reduce the incidence of local venous irritation. Electrolyte additives should be spread throughout the day. Irritating additive medications may need to be injected at another venous site.
Read the entire FDA prescribing information for Aminosyn II 3.5 (Amino Acid Injection in Dextrose Injection) »
Additional Aminosyn II 3.5% in 5% Dextrose Information
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Weight Loss Wisdom
Get tips, recipes and inspiration.